Altered O
intrinsic O
and O
extrinsic O
connectivity O
in O
schizophrenia O
Schizophrenia O
is O
a O
disorder O
characterized O
by O
functional O
dysconnectivity O
among O
distributed O
brain O
regions O
. O

However O
, O
it O
is O
unclear O
how O
causal O
influences O
among O
large-scale O
brain O
networks O
are O
disrupted O
in O
schizophrenia O
. O

In O
this O
study O
, O
we O
used O
dynamic O
causal O
modeling O
( O
DCM O
) O
to O
assess O
the O
hypothesis O
that O
there O
is O
aberrant O
directed O
( O
effective O
) O
connectivity O
within O
and O
between O
three O
key O
large-scale O
brain O
networks O
( O
the O
dorsal O
attention O
network O
, O
the O
salience O
network O
and O
the O
default O
mode O
network O
) O
in O
schizophrenia O
during O
a O
working O
memory O
task O
. O

Functional O
MRI O
data O
during O
an O
n-back O
task O
from O
40 O
patients O
with O
schizophrenia O
and O
62 O
healthy O
controls O
were O
analyzed O
. O

Using O
hierarchical O
modeling O
of O
between-subject O
effects O
in O
DCM O
with O
Parametric O
Empirical O
Bayes O
, O
we O
found O
that O
intrinsic O
( O
within-region O
) O
and O
extrinsic O
( O
between-region O
) O
effective O
connectivity O
involving O
prefrontal O
regions O
were O
abnormal O
in O
schizophrenia O
. O

Specifically O
, O
in O
patients O
( O
i O
) O
inhibitory O
self-connections O
in O
prefrontal O
regions O
of O
the O
dorsal O
attention O
network O
were O
decreased O
across O
task O
conditions O
; O
( O
ii O
) O
extrinsic O
connectivity O
between O
regions O
of O
the O
default O
mode O
network O
was O
increased O
; O
specifically O
, O
from O
posterior O
cingulate O
cortex O
to O
the O
medial O
prefrontal O
cortex O
; O
( O
iii O
) O
between-network O
extrinsic O
connections O
involving O
the O
prefrontal O
cortex O
were O
altered O
; O
( O
iv O
) O
connections O
within O
networks O
and O
between O
networks O
were O
correlated O
with O
the O
severity O
of O
clinical O
symptoms O
and O
impaired O
cognition O
beyond O
working O
memory O
. O

In O
short O
, O
this O
study O
revealed O
the O
predominance O
of O
reduced O
synaptic O
efficacy O
of O
prefrontal O
efferents O
and O
afferents O
in O
the O
pathophysiology O
of O
schizophrenia O
. O

Highlights O
A O
first O
use O
of O
hierarchical O
modeling O
of O
effective O
connectivity O
to O
characterize O
large-scale O
networks O
in O
schizophrenia O
. O

Intrinsic O
and O
extrinsic O
effective O
connectivity O
involving O
prefrontal O
regions O
were O
abnormal O
in O
schizophrenia O
. O

Diagnostic O
connections O
could O
predict O
the O
severity O
of O
clinical O
symptoms O
and O
cognition O
in O
schizophrenia O
. O

Materials O
and O
methods O
Participants O
Patients O
with O
schizophrenia O
were O
recruited O
from O
the O
Department O
of O
Psychiatry O
, O
Renmin O
Hospital O
of O
Wuhan O
University O
( O
Wuhan O
, O
China O
) O
. O

The O
Structured O
Clinical O
Interview O
for O
the O
Diagnostic O
and O
Statistical O
Manual O
of O
Mental O
Disorder O
, O
4th O
edition O
( O
DSM-IV O
) O
( O
SCID O
) O
was O
administered O
, O
to O
confirm O
diagnosis O
. O

The O
patients O
also O
met O
the O
following O
inclusion O
criteria O
: O
( O
1 O
) O
the O
total O
score O
of O
Positive O
and O
Negative O
Syndrome O
Scale O
( O
PANSS O
) O
was O
over O
60 O
, O
( O
2 O
) O
duration O
of O
illness O
was O
< O
5 O
years O
, O
( O
3 O
) O
18–45 O
years O
of O
age O
, O
( O
4 O
) O
at O
least O
9 O
years O
of O
education O
, O
( O
5 O
) O
right-handed O
, O
and O
( O
6 O
) O
Han O
Chinese O
. O

Patients O
were O
excluded O
if O
they O
met O
the O
diagnosis O
criteria O
of O
any O
other O
DSM O
Axis-I O
disorders O
, O
had O
severe O
physical O
illness O
including O
cardiovascular O
disease O
, O
had O
received O
electroconvulsive O
therapy O
six O
months O
prior O
to O
recruitment O
, O
or O
had O
structural O
changes O
in O
the O
brain O
( O
such O
as O
a O
white O
matter O
lesion O
) O
diagnosed O
by O
a O
radiologist O
. O

Healthy O
controls O
were O
recruited O
by O
word O
of O
mouth O
and O
bulletin O
board O
postings O
both O
in O
the O
hospital O
and O
nearby O
communities O
. O

The O
healthy O
controls O
, O
who O
matched O
the O
patients O
on O
age O
, O
gender O
and O
educational O
level O
, O
had O
the O
same O
inclusion O
and O
exclusion O
criteria O
; O
except O
that O
healthy O
controls O
were O
excluded O
if O
they O
or O
their O
first-relatives O
met O
any O
diagnosis O
of O
a O
psychiatric O
disorder O
according O
to O
the O
DSM-IV O
criteria O
. O

Fifty-one O
patients O
and O
66 O
healthy O
controls O
were O
recruited O
. O

All O
the O
patients O
were O
receiving O
antipsychotic O
medications O
, O
which O
were O
converted O
to O
their O
chlorpromazine O
equivalents O
. O

Six O
patients O
and O
4 O
healthy O
controls O
were O
excluded O
from O
the O
data O
analyses O
due O
to O
severe O
head O
motion O
during O
scanning O
( O
x O
, O
y O
, O
z O
translation O
> O
3 O
mm O
or O
x O
, O
y O
, O
z O
rotation O
> O
3° O
) O
, O
3 O
patients O
were O
excluded O
due O
to O
extremely O
high O
values O
in O
the O
mean O
frame O
displacement O
( O
FD O
) O
value O
and O
2 O
patients O
were O
excluded O
due O
to O
extreme O
low O
scores O
in O
the O
0-back O
performance O
( O
see O
details O
in O
Methodology O
) O
. O

Finally O
, O
40 O
patients O
and O
62 O
normal O
controls O
were O
included O
in O
the O
following O
data O
analyses O
. O

Each O
participant O
or O
at O
least O
one O
first-degree O
relative O
for O
each O
patient O
provided O
informed O
consent O
before O
participation O
. O

The O
Ethics O
Committee O
of O
Renmin O
Hospital O
of O
Wuhan O
University O
and O
the O
Institutional O
Review O
Board O
of O
the O
Institute O
of O
Psychology O
, O
Chinese O
Academy O
of O
Sciences O
approved O
the O
study O
. O

Experimental O
design O
and O
task O
The O
WM O
paradigm O
used O
a O
blocked O
design O
, O
numeric O
n-back O
task O
, O
with O
numbers O
0–9 O
as O
stimuli O
, O
which O
has O
been O
used O
in O
previous O
studies O
. O

The O
paradigm O
alternated O
between O
rest O
and O
task O
. O

Rest O
periods O
, O
in O
which O
subjects O
were O
instructed O
to O
fixate O
on O
a O
cross O
at O
the O
centre O
of O
the O
screen O
, O
lasted O
for O
5 O
scans O
( O
i.e O
. O

10 O
s O
) O
. O

The O
task O
consisted O
of O
two O
conditions O
, O
0-back O
( O
baseline O
) O
and O
2-back O
( O
WM O
load O
condition O
) O
, O
arranged O
as O
0-2-0-0-2-2-2-0-0-2-2-0 O
, O
each O
with O
duration O
of O
12 O
scans O
( O
i.e O
. O

24 O
s O
) O
. O

Before O
each O
block O
a O
visual O
cue O
of O
one O
scan O
( O
i.e O
. O

2 O
s O
) O
was O
presented O
, O
indicating O
the O
condition O
of O
the O
subsequent O
block O
. O

Each O
block O
comprised O
12 O
stimuli O
, O
three O
of O
which O
were O
targets O
, O
each O
presented O
for O
1000 O
ms O
with O
a O
1000 O
ms O
interstimulus O
interval O
. O

Subjects O
were O
instructed O
to O
match O
the O
current O
number O
to O
a O
target O
, O
either O
the O
number O
9 O
( O
0-back O
) O
or O
the O
number O
presented O
two O
trials O
earlier O
( O
2-back O
) O
. O

In O
order O
to O
ensure O
compliance O
during O
the O
subsequent O
acquisition O
, O
a O
training O
session O
was O
conducted O
prior O
to O
scanning O
. O

The O
training O
procedure O
was O
the O
same O
as O
that O
used O
in O
our O
previous O
study O
. O

In O
brief O
, O
the O
training O
task O
was O
similar O
to O
the O
formal O
task O
, O
though O
only O
one O
0-back O
and O
one O
2-back O
trial O
were O
included O
. O

Accuracy O
was O
displayed O
on O
the O
monitor O
at O
the O
end O
of O
the O
practice O
task O
, O
and O
patients O
were O
provided O
with O
further O
practice O
opportunities O
, O
until O
they O
clearly O
understood O
the O
task O
. O

Cognition O
assessments O
Several O
cognitive O
assessments O
were O
conducted O
outside O
of O
scanning O
. O

These O
included O
the O
Digit O
Symbol O
Coding O
task O
, O
Digit O
Span O
( O
forward O
and O
backward O
) O
and O
Category O
Fluency O
test O
. O

The O
Digit O
Symbol O
Coding O
task O
assesses O
information O
processing O
speed O
and O
is O
known O
to O
detect O
impairments O
in O
schizophrenia O
reliably O
. O

The O
Category O
Fluency O
test O
is O
the O
cognitive O
assessment O
with O
the O
second O
largest O
effect O
size O
, O
followed O
by O
the O
Digit O
Symbol O
Coding O
task O
. O

The O
Digit O
Span O
( O
forward O
and O
backward O
) O
is O
a O
general O
assessment O
of O
attention O
and O
working O
memory O
capacity O
. O

MRI O
data O
acquisition O
and O
preprocessing O
MRI O
data O
were O
acquired O
from O
the O
Radiology O
Department O
of O
Renmin O
Hospital O
of O
Wuhan O
University O
with O
a O
General O
Electric O
HDxt O
3.0T O
Scanner O
. O

Whole-brain O
functional O
scans O
were O
collected O
in O
32 O
axial O
slices O
using O
an O
echo-planar O
imaging O
( O
EPI O
) O
sequence O
( O
repetition O
time O
= O
2000 O
ms O
, O
echo O
time O
= O
30 O
ms O
; O
flip O
angle O
= O
90° O
; O
matrix O
= O
64 O
× O
64 O
; O
field O
of O
view O
= O
220 O
mm O
× O
220 O
mm O
; O
slice O
thickness O
= O
4 O
mm O
; O
and O
slice O
gap O
= O
0.6 O
mm O
) O
. O

Anatomical O
images O
were O
acquired O
using O
a O
high-resolution O
T1-weighted O
sequence O
( O
repetition O
time O
= O
7.8 O
ms O
; O
echo O
time O
= O
3.0 O
ms O
; O
flip O
angle O
= O
7° O
; O
matrix O
= O
256 O
× O
256 O
; O
field O
of O
view O
= O
256 O
× O
256 O
mm2 O
; O
slice O
thickness O
= O
1 O
mm O
) O
composed O
of O
188 O
slices O
in O
a O
sagittal O
orientation O
. O

Initial O
image O
preprocessing O
was O
performed O
using O
Statistical O
Parametric O
Mapping O
( O
SPM12 O
) O
( O
http O
: O
//www.fil.ion.ucl.ac.uk/spm/ O
) O
and O
included O
slice O
timing O
correction O
, O
motion O
correction O
, O
structural O
and O
functional O
image O
co-registration O
, O
segmentation O
, O
normalization O
( O
based O
on O
each O
participant O
's O
structural O
image O
) O
to O
the O
Montreal O
Neurological O
Institute O
( O
MNI O
) O
152 O
template O
, O
and O
smoothing O
using O
a O
kernel O
with O
a O
full-width O
half O
maximum O
of O
6 O
mm O
. O

The O
normalized O
images O
were O
interpolated O
to O
a O
resolution O
of O
3 O
× O
3 O
× O
3 O
mm3 O
. O

Furthermore O
, O
based O
on O
the O
head O
motion O
parameters O
obtained O
after O
realignment O
, O
we O
computed O
the O
volume-based O
frame-wise O
displacement O
( O
FD O
) O
to O
quantify O
head O
motion O
. O

Behavioral O
analysis O
To O
assess O
behavioral O
performance O
of O
the O
n-back O
task O
, O
the O
sensitivity O
index O
, O
d′ O
from O
signal O
detection O
theory O
was O
used O
. O

The O
score O
d′ O
describes O
sensitivity O
; O
i.e. O
, O
the O
ability O
to O
separate O
signal O
( O
“ O
true O
” O
events O
) O
and O
noise O
( O
“ O
false O
” O
events O
) O
. O

The O
score O
was O
computed O
separately O
for O
0-back O
condition O
and O
2-back O
condition O
( O
d′0 O
and O
d′2 O
) O
for O
each O
participant O
. O

A O
repeated O
measures O
ANOVA O
with O
conditions O
as O
within-group O
factor O
and O
diagnosis O
as O
between-group O
factor O
was O
conducted O
using O
SPSS O
20.0 O
. O

Two O
sample O
t-tests O
were O
used O
to O
assess O
group O
differences O
in O
the O
Digit O
Symbol O
Coding O
task O
, O
Digit O
Span O
task O
and O
Category O
Fluency O
task O
. O

GLM O
analysis O
A O
general O
linear O
model O
( O
GLM O
) O
was O
constructed O
with O
regressors O
for O
each O
of O
the O
two O
task O
conditions O
( O
0-back O
and O
2-back O
) O
as O
well O
as O
the O
instruction O
cues O
for O
the O
task O
blocks O
. O

To O
regress O
out O
motion O
and O
physiological O
noise O
( O
e.g. O
, O
of O
cardiac O
and O
respiratory O
origin O
) O
, O
additional O
covariates O
were O
included O
to O
model O
: O
( O
1 O
) O
six O
head O
motion O
parameters O
obtained O
by O
rigid O
body O
head O
motion O
correction O
and O
( O
2 O
) O
five O
principal O
components O
from O
an O
anatomically O
defined O
noise O
VOI O
( O
composed O
of O
white O
matter O
and O
cerebrospinal O
fluid O
) O
, O
an O
approach O
that O
has O
been O
shown O
to O
accurately O
describe O
physiological O
noise O
in O
grey O
matter O
. O

Finally O
, O
a O
highpass O
filter O
with O
a O
cutoff O
of O
250 O
s O
( O
0.004 O
Hz O
) O
was O
implemented O
to O
remove O
low O
frequency O
drifts O
while O
retaining O
most O
task-related O
frequencies O
. O

At O
the O
group O
level O
, O
random-effects O
group O
analyses O
were O
conducted O
using O
an O
ANOVA O
, O
with O
diagnosis O
as O
a O
between-group O
factor O
and O
task O
condition O
as O
a O
within-group O
factor O
. O

If O
not O
mentioned O
otherwise O
, O
significant O
effects O
in O
fMRI O
analyses O
were O
defined O
by O
a O
corrected O
voxel-level O
family-wise O
error O
( O
FWE O
) O
threshold O
of O
p O
< O
0.05 O
. O

Dynamic O
causal O
modeling O
VOI O
selections O
Regions O
that O
showed O
differential O
activation O
between O
the O
patients O
and O
control O
groups O
in O
the O
context O
of O
WM O
( O
i.e. O
, O
a O
significant O
interaction O
between O
diagnosis O
and O
task O
) O
or O
activation/deactivation O
in O
association O
with O
the O
task O
( O
i.e. O
, O
a O
significant O
main O
effect O
of O
task O
) O
were O
considered O
as O
volumes O
of O
interest O
( O
VOI O
) O
for O
use O
in O
subsequent O
DCM O
analysis O
. O

Furthermore O
, O
in O
order O
to O
focus O
on O
the O
three O
networks O
of O
interest O
, O
i.e. O
, O
dorsal O
attention O
network O
( O
DAN O
) O
, O
salience O
network O
( O
SN O
) O
, O
and O
default-mode O
network O
( O
DMN O
) O
, O
preexisting O
templates O
were O
used O
as O
masks O
to O
identify O
peak O
voxels O
in O
the O
core O
regions O
in O
each O
of O
the O
three O
networks O
. O

This O
procedure O
defined O
four O
nodes O
for O
the O
DAN O
: O
the O
bilateral O
frontal O
eye O
field O
( O
FEF O
) O
and O
the O
bilateral O
superior O
parietal O
lobule O
( O
SPL O
) O
; O
three O
nodes O
for O
the O
SN O
: O
the O
SMA/ACC O
, O
the O
left O
anterior O
insula O
( O
AI O
) O
and O
the O
right O
AI O
; O
two O
nodes O
for O
the O
DMN O
: O
the O
medial O
prefrontal O
cortex O
( O
MPFC O
) O
and O
the O
posterior O
cingulate O
cortex O
( O
PCC O
) O
. O

The O
group-level O
VOI O
locations O
are O
listed O
in O
Table O
2 O
. O

These O
were O
obtained O
by O
intersecting O
functional O
defined O
templates O
with O
regions O
showing O
a O
significant O
interaction O
between O
diagnosis O
and O
task O
or O
main O
effect O
of O
task O
at O
a O
lesser O
conservative O
threshold O
of O
cluster-level O
FWE O
p O
< O
0.05 O
( O
cluster-defining O
threshold O
p O
= O
0.001 O
) O
. O

We O
then O
searched O
for O
the O
local O
maximum O
within O
the O
group-level O
VOI O
and O
summarized O
the O
regional O
response O
with O
the O
first O
eigenvariate O
of O
( O
confound-corrected O
) O
voxels O
within O
a O
6 O
mm O
radius O
. O

For O
the O
participants O
in O
which O
no O
supra-threshold O
voxels O
were O
identified O
, O
the O
first O
eigenvariate O
was O
extracted O
from O
a O
6 O
mm O
sphere O
centered O
at O
the O
group-level O
maximum O
. O

Individual O
level O
DCM O
specification O
and O
inversion O
DCM O
is O
a O
framework O
for O
specifying O
, O
estimating O
and O
comparing O
generative O
models O
of O
imaging O
time O
series O
. O

Here O
we O
used O
the O
basic O
( O
deterministic O
) O
model O
for O
fMRI O
, O
in O
which O
a O
vector O
z O
∈ O
ℝn O
represents O
mass O
neural O
activity O
of O
each O
brain O
region O
at O
a O
given O
time O
. O

The O
derivative O
of O
z O
with O
respect O
to O
time O
can O
be O
written O
as O
: O
where O
u O
is O
the O
experimental O
input O
and O
θn O
are O
neuronal O
coupling O
parameters O
that O
determine O
the O
strength O
of O
connections O
within O
and O
between O
brain O
regions O
. O

This O
function O
is O
approximated O
using O
: O
where O
parameter O
matrix O
A O
∈ O
ℝn O
× O
n O
represents O
the O
connectivity O
within O
and O
between O
each O
of O
the O
n O
regions O
( O
which O
in O
this O
study O
is O
the O
average O
connectivity O
of O
0-back O
and O
2-back O
conditions O
) O
, O
B O
( O
j O
) O
∈ O
ℝn O
× O
n O
is O
the O
modulatory O
effect O
of O
experimental O
manipulation O
j O
on O
each O
connection O
and O
C O
∈ O
ℝn O
× O
J O
is O
the O
direct O
driving O
influence O
of O
each O
of O
the O
J O
experimental O
conditions O
on O
each O
region O
. O

The O
predicted O
neuronal O
activity O
enters O
a O
haemodynamic O
model O
that O
incorporates O
a O
model O
of O
neurovascular O
coupling O
and O
the O
subsequent O
BOLD O
response O
. O

This O
provides O
the O
predicted O
fMRI O
time O
series O
that O
one O
would O
expect O
to O
measure O
, O
given O
the O
connectivity O
parameters O
θn O
= O
( O
A O
, O
B O
, O
C O
) O
. O

We O
specified O
a O
DCM O
for O
each O
participant O
. O

Model O
specification O
involved O
setting O
prior O
variances O
on O
the O
parameters O
in O
matrices O
A O
, O
B O
and O
C O
, O
where O
a O
prior O
variance O
of O
zero O
‘ O
switches O
off O
’ O
a O
connection O
and O
a O
non-zero O
prior O
variance O
‘ O
switches O
on O
’ O
a O
connection O
– O
so O
that O
it O
can O
be O
informed O
by O
data O
. O

Here O
, O
there O
were O
two O
experimental O
inputs O
( O
J O
= O
2 O
) O
: O
the O
main O
effect O
of O
task O
( O
all O
0-back O
and O
2-back O
events O
) O
and O
working O
memory O
load O
( O
contrasting O
0-back O
with O
2-back O
) O
. O

Task O
entered O
the O
model O
as O
a O
driving O
input O
( O
by O
setting O
the O
appropriate O
priors O
in O
matrix O
C O
) O
. O

Working O
memory O
load O
entered O
the O
model O
as O
a O
modulatory O
input O
on O
each O
region O
's O
self-connection O
( O
i.e. O
, O
intrinsic O
connection O
) O
by O
setting O
the O
appropriate O
priors O
on O
matrix O
B O
. O

The O
self-connections O
regulate O
a O
region O
's O
response O
to O
its O
inputs O
; O
i.e. O
, O
they O
provide O
gain O
control O
in O
the O
model O
, O
akin O
to O
inhibitory O
inter-neurons O
– O
and O
consequent O
excitation-inhibition O
balance O
– O
in O
the O
brain O
. O

Thus O
, O
we O
modeled O
working O
memory O
load O
as O
modifying O
the O
sensitivity O
of O
each O
region O
to O
input O
from O
the O
rest O
of O
the O
network O
. O

Each O
subject O
's O
model O
was O
inverted O
, O
providing O
estimates O
of O
the O
connection O
strength O
parameters O
θ O
( O
n O
) O
which O
best O
explained O
the O
observed O
data O
. O

The O
resulting O
posterior O
densities O
were O
normally O
distributed O
, O
with O
expected O
values O
and O
covariance O
( O
uncertainty O
) O
. O

Model O
estimation O
additionally O
provided O
the O
free O
energy O
approximation O
to O
log O
model O
evidence O
F O
, O
which O
scores O
the O
quality O
of O
each O
model O
in O
terms O
of O
accuracy O
and O
complexity O
: O
where O
y O
is O
the O
data O
and O
m O
is O
the O
model O
. O

One O
uses O
the O
free O
energy O
F O
to O
compare O
competing O
models O
, O
in O
order O
to O
find O
the O
least O
complex O
model O
of O
the O
data O
that O
accurately O
explains O
the O
most O
variance O
. O

Empirical O
Bayes O
for O
group O
DCM O
Having O
fitted O
each O
subject O
's O
DCM O
to O
their O
data O
, O
we O
next O
performed O
a O
second O
level O
analysis O
to O
estimate O
the O
group O
mean O
and O
the O
effect O
of O
diagnosis O
for O
each O
connection O
. O

This O
used O
recently O
developed O
routines O
for O
modeling O
connectivity O
at O
the O
group O
level O
( O
Parametric O
Empirical O
Bayes O
) O
in O
the O
context O
of O
DCM O
. O

Parametric O
Empirical O
Bayes O
( O
PEB O
) O
is O
a O
between-subject O
hierarchical O
or O
empirical O
Bayesian O
model O
over O
parameters O
that O
models O
how O
individual O
( O
within-subject O
) O
connections O
relate O
to O
group O
or O
condition O
means O
. O

This O
hierarchical O
approach O
treats O
each O
connection O
as O
a O
random O
( O
between-subject O
) O
effect O
, O
which O
is O
modeled O
by O
adding O
a O
random O
Gaussian O
variation O
to O
subject-specific O
predictions O
, O
based O
upon O
the O
group O
mean O
connectivity O
as O
well O
as O
between-subject O
effects O
such O
as O
diagnosis O
or O
age O
. O

This O
parametric O
random O
effects O
modeling O
is O
important O
because O
, O
unlike O
a O
classical O
test O
( O
e.g O
. O

t-test O
) O
, O
it O
uses O
the O
full O
posterior O
density O
over O
the O
parameters O
from O
each O
subject O
's O
DCM O
– O
both O
the O
expected O
strength O
of O
each O
connection O
and O
the O
associated O
uncertainty O
( O
i.e O
. O

posterior O
covariance O
) O
– O
to O
inform O
the O
group-level O
result O
( O
i.e. O
, O
group O
differences O
) O
. O

A O
PEB O
model O
has O
the O
following O
form O
: O
Starting O
with O
the O
last O
line O
, O
the O
observed O
fMRI O
data O
yi O
for O
subject O
i O
is O
generated O
by O
function O
Γi O
( O
1 O
) O
, O
which O
here O
is O
the O
subject O
's O
DCM O
, O
with O
parameters O
θ O
( O
1 O
) O
and O
observation O
noise O
ϵi O
( O
1 O
) O
. O

The O
contribution O
of O
the O
PEB O
framework O
is O
that O
the O
DCM O
parameters O
θ O
( O
1 O
) O
are O
themselves O
represented O
by O
a O
group O
or O
second-level O
model O
, O
written O
on O
the O
second O
line O
of O
the O
equation O
. O

The O
second O
level O
function O
Γ O
( O
2 O
) O
has O
parameters O
( O
e.g. O
, O
average O
connection O
strengths O
) O
θ O
( O
2 O
) O
, O
plus O
between-subject O
variability O
ϵ O
( O
2 O
) O
. O

Finally O
, O
these O
second O
level O
parameters O
have O
priors O
, O
with O
mean O
η O
, O
as O
specified O
on O
the O
first O
line O
of O
the O
equation O
. O

In O
this O
study O
, O
the O
first O
( O
within-subject O
) O
level O
of O
the O
model O
is O
the O
standard O
deterministic O
DCM O
for O
fMRI O
, O
where O
the O
parameters O
correspond O
to O
effective O
connectivity O
( O
please O
see O
above O
) O
. O

The O
second O
( O
between-subject O
) O
level O
model O
Γ O
( O
2 O
) O
is O
simply O
a O
GLM O
with O
the O
form O
: O
where O
X O
∈ O
ℝS O
× O
C O
is O
the O
design O
matrix O
( O
S O
is O
the O
number O
of O
subjects O
, O
C O
is O
the O
number O
of O
covariates O
) O
, O
IP O
is O
the O
identity O
matrix O
of O
dimension O
P O
( O
where O
P O
is O
the O
number O
of O
connection O
parameters O
in O
the O
DCM O
) O
and O
the O
operator O
⊗ O
is O
the O
Kronecker O
product O
that O
duplicates O
each O
element O
of O
the O
design O
matrix O
for O
each O
DCM O
parameter O
. O

In O
other O
words O
, O
this O
model O
allows O
for O
every O
between O
subject-effect O
to O
be O
expressed O
at O
every O
within-subject O
effect O
. O

The O
parameters O
of O
the O
GLM O
are O
β O
⊂ O
θ O
( O
2 O
) O
. O

Thus O
, O
we O
had O
one O
β O
parameter O
representing O
the O
effect O
of O
each O
( O
between-subject O
) O
covariate O
on O
each O
DCM O
connection O
. O

The O
priors O
on O
these O
second O
level O
parameters O
were O
set O
to O
match O
the O
priors O
of O
the O
first O
level O
parameters O
. O

In O
order O
to O
identify O
differences O
between O
patients O
with O
schizophrenia O
and O
normal O
controls O
, O
we O
included O
two O
covariates O
of O
interest O
in O
the O
design O
matrix O
X O
: O
the O
group O
mean O
and O
diagnosis O
. O

We O
also O
included O
the O
working O
memory O
performance O
indexed O
by O
the O
ratio O
between O
d′2 O
score O
and O
d′0 O
score O
and O
the O
interaction O
between O
diagnosis O
and O
performance O
as O
nuisance O
covariates O
, O
in O
order O
to O
exclude O
the O
potential O
influence O
of O
performance O
components O
on O
the O
group O
mean O
and O
diagnosis O
effect O
. O

The O
between-subject O
variability O
ϵ O
( O
2 O
) O
with O
precision O
Π O
( O
2 O
) O
was O
parameterized O
using O
a O
single O
precision O
parameter O
γ O
: O
where O
Q0 O
is O
the O
lower O
bound O
on O
precision O
, O
which O
takes O
on O
a O
small O
positive O
value O
, O
and O
the O
precision O
parameter O
γ O
⊂ O
θ O
( O
2 O
) O
scales O
a O
precision O
component O
Q1 O
. O

Here O
, O
we O
used O
the O
defaults O
in O
SPM O
, O
which O
sets O
Q1 O
to O
, O
where O
pC O
is O
the O
prior O
covariance O
matrix O
of O
a O
single O
subject O
's O
DCM O
parameters O
and O
β O
= O
16 O
. O

To O
summarize O
, O
the O
PEB O
model O
estimates O
the O
effect O
of O
each O
covariate O
on O
each O
connection O
( O
both O
the O
group O
mean O
and O
any O
group O
differences O
) O
, O
as O
well O
as O
estimating O
the O
between-subject O
variability O
. O

The O
parameters O
of O
the O
PEB O
model O
were O
estimated O
using O
a O
standard O
variational O
Laplace O
procedure O
, O
as O
is O
usually O
applied O
in O
DCM O
. O

Bayesian O
model O
reduction O
To O
evaluate O
how O
the O
connectivity O
of O
patients O
with O
schizophrenia O
differs O
from O
that O
of O
normal O
controls O
, O
we O
used O
Bayesian O
model O
comparison O
to O
explore O
the O
space O
of O
possible O
hypotheses O
( O
models O
) O
, O
where O
each O
hypothesis O
or O
model O
assumes O
that O
a O
different O
combination O
of O
the O
connections O
could O
exist O
across O
participants O
or O
show O
phenotypic O
variance O
. O

Candidate O
PEB O
models O
were O
obtained O
by O
removing O
one O
or O
more O
( O
second O
level O
) O
parameters O
from O
the O
full O
PEB O
model O
( O
described O
above O
) O
to O
produce O
reduced O
forms O
of O
the O
full O
model O
that O
differed O
only O
in O
their O
priors O
. O

We O
did O
this O
using O
Bayesian O
model O
reduction O
( O
BMR O
) O
that O
enables O
the O
evidence O
and O
parameters O
of O
nested O
( O
reduced O
) O
models O
to O
be O
derived O
directly O
from O
a O
full O
model O
. O

This O
provides O
an O
efficient O
search O
of O
the O
model O
space O
by O
scoring O
each O
reduced O
model O
, O
based O
on O
its O
log O
model-evidence O
or O
free O
energy O
; O
for O
details O
, O
see O
. O

The O
( O
greedy O
) O
search O
algorithm O
used O
BMR O
to O
iteratively O
prune O
connection O
parameters O
from O
the O
full O
PEB O
model O
, O
until O
model-evidence O
started O
to O
decrease O
. O

The O
parameters O
of O
the O
best O
256 O
pruned O
models O
were O
then O
averaged O
, O
weighted O
by O
their O
evidence O
( O
Bayesian O
Model O
Averaging O
) O
. O

To O
summarize O
the O
DCM O
analysis O
pipeline O
, O
we O
first O
specified O
a O
DCM O
for O
each O
subject O
and O
fitted O
it O
to O
their O
data O
, O
providing O
estimates O
of O
the O
connectivity O
parameters O
. O

These O
subject-specific O
estimates O
( O
expected O
values O
and O
covariance O
) O
were O
taken O
to O
the O
group O
level O
and O
modeled O
using O
a O
Bayesian O
GLM O
( O
i.e. O
, O
a O
PEB O
model O
) O
. O

The O
parameters O
of O
the O
GLM O
represent O
the O
group O
average O
of O
each O
connectivity O
parameter O
, O
as O
well O
as O
any O
group O
differences O
between O
patients O
and O
controls O
. O

We O
than O
used O
Bayesian O
model O
reduction O
to O
search O
over O
hundreds O
of O
reduced O
PEB O
models O
with O
different O
combinations O
of O
connections O
( O
and O
group O
differences O
) O
. O

The O
best O
models O
from O
this O
search O
were O
combined O
using O
Bayesian O
model O
averaging O
. O

We O
report O
these O
averages O
in O
the O
Results O
section O
. O

Clinical O
correlates O
of O
differentiated O
connections O
Having O
identified O
the O
connections O
that O
differed O
between O
patients O
and O
controls O
in O
the O
working O
memory O
task O
, O
we O
next O
asked O
whether O
the O
strength O
of O
these O
connections O
correlated O
with O
the O
severity O
of O
symptoms O
in O
patients O
. O

As O
we O
had O
a O
large O
number O
of O
variables O
, O
we O
did O
not O
include O
these O
in O
the O
PEB O
model O
directly O
; O
instead O
, O
we O
used O
a O
( O
post O
hoc O
) O
canonical O
variates O
analysis O
( O
CVA O
) O
to O
identify O
linear O
relationships O
between O
the O
two O
sets O
of O
measures O
( O
strength O
of O
effective O
connectivity O
and O
clinical O
symptoms O
) O
. O

This O
resulted O
in O
pairs O
of O
significantly O
correlated O
canonical O
variables O
( O
i.e. O
, O
latent O
connectivity O
and O
symptom O
profiles O
) O
. O

Using O
the O
same O
analysis O
, O
we O
asked O
whether O
our O
cognitive O
scores O
could O
be O
predicted O
by O
the O
effective O
connectivity O
. O

Effect O
of O
antipsychotic O
medication O
In O
order O
to O
ameliorate O
the O
confounding O
effect O
of O
antipsychotic O
medication O
on O
group O
differences O
, O
we O
included O
the O
chlorpromazine O
equivalents O
of O
antipsychotic O
medication O
as O
a O
nuisance O
covariate O
– O
in O
addition O
to O
the O
nuisance O
covariates O
above O
( O
working O
memory O
performance O
and O
interaction O
between O
diagnosis O
and O
performance O
) O
– O
in O
the O
between O
subject O
design O
matrix O
. O

The O
main O
effects O
of O
group O
were O
unchanged O
when O
including O
antipsychotic O
medication O
as O
a O
between O
subject O
effect O
. O

We O
present O
the O
effect O
of O
the O
antipsychotic O
medication O
and O
other O
nuisance O
covariates O
on O
effective O
connectivity O
in O
the O
supplementary O
materials O
( O
Fig O
. O

S1 O
) O
. O

We O
also O
include O
the O
chlorpromazine O
equivalents O
of O
antipsychotic O
medication O
into O
the O
CVA O
models O
while O
exploring O
the O
clinical O
correlates O
of O
differentiate O
connections O
. O

